Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial

• DOI: 10.1080/09273948.2023.2262015
• Publication Date: 2024-01-09T18:33:20Z
• Authors: Milan Shah; Thomas Albini; Quan Nguyen; Charles Wykoff; Mark Barakat; Rahul N. Khurana; Barry Kapik; Thomas A. Ciulla
• Keywords: CLs upper limits; Etiology

To explore the efficacy of CLS-TA, a proprietary suprachoroidal injectable suspension triamcinolone acetonide, in noninfectious uveitis (NIU) with macular edema (ME), categorized by anatomic subtype.